Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05783869

Study of Bronchiectasis and Associated Cardiovascular Comorbidities

Effect of Cardiovascular Comorbidities on Disease Severity and Quality of Life in Patients With Acute Exacerbation of Non-cystic Fibrosis Bronchiectasis

Status
Recruiting
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Effect of cardiovascular comorbidities on disease severity and quality of life in Patients with acute exacerbation of non-cystic fibrosis bronchiectasis

Detailed description

The study will include patients with bronchiectasis, and in an attempt to correlate the effect and burden of cardiovascular comorbidities in those patients, we will study the quality of life in those patients in comparison to the control group ( patients with bronchiectasis and without any other comorbidities) using SF-36 quality of life questionnaire. We will also study the inflammatory markers in both groups using D-dimer, BNP, and CRP and correlate them with the frequency of hospital admission, the severity of symptoms, and the general health state.

Conditions

Interventions

TypeNameDescription
DEVICEEchocardiographyechocardiographic study of both groups

Timeline

Start date
2023-03-25
Primary completion
2026-09-01
Completion
2026-11-01
First posted
2023-03-24
Last updated
2025-05-11

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05783869. Inclusion in this directory is not an endorsement.

Study of Bronchiectasis and Associated Cardiovascular Comorbidities (NCT05783869) · Clinical Trials Directory